Inventor
WILLINGHAM STEPHEN
US18 patents
⚠️ This page may combine multiple inventors who share the name “WILLINGHAM STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
13 patentsUS9623079B2Apr 18, 2017
Methods for achieving therapeutically effective doses of anti-CD47 agents for treating cancer
UNIV LELAND STANFORD JUNIOR26 citations97
US11136391B2Oct 5, 2021
Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody
UNIV LELAND STANFORD JUNIOR9 citations93
US10301387B2May 28, 2019
Methods for achieving therapeutically effective doses of anti-CD47 agents
UNIV LELAND STANFORD JUNIOR11 citations92
US11518806B2Dec 6, 2022
Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody
UNIV LELAND STANFORD JUNIOR6 citations84
US11603404B2Mar 14, 2023
Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody
UNIV LELAND STANFORD JUNIOR3 citations83
US10064925B2Sep 4, 2018
Use of anti-CD47 agents to enhance immunization
UNIV LELAND STANFORD JUNIOR7 citations82
US10344094B2Jul 9, 2019
Treatment of cancer with dual targeting of CD47 and EGFR
UNIV LELAND STANFORD JUNIOR6 citations80
US12258399B2Mar 25, 2025
Methods for achieving therapeutically effective doses of anti-CD47 agents
UNIV LELAND STANFORD JUNIOR0 citations62
US11104731B2Aug 31, 2021
Compositions for achieving therapeutically effective doses of anti-CD47 agents
UNIV LELAND STANFORD JUNIOR0 citations62
US12258403B2Mar 25, 2025
Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody
UNIV LELAND STANFORD JUNIOR0 citations61
US11154600B2Oct 26, 2021
Use of anti-CD47 agents to enhance immunization
UNIV LELAND STANFORD JUNIOR0 citations60
US12037402B2Jul 16, 2024
Treatment of cancer with dual targeting of CD47 and EGFR
UNIV LELAND STANFORD JUNIOR0 citations59
US11130813B2Sep 28, 2021
Treatment of cancer with dual targeting of CD47 and EGFR
UNIV LELAND STANFORD JUNIOR0 citations59
CORVUS PHARMACEUTICALS INC
5 patentsUS11040040B2Jun 22, 2021
Methods of treating cancer
CORVUS PHARMACEUTICALS INC2 citations70
US10912776B2Feb 9, 2021
Methods of treating cancer
CORVUS PHARMACEUTICALS INC3 citations68
US12174192B2Dec 24, 2024
Methods for detecting and treating cancers having adenosine pathway activation
CORVUS PHARMACEUTICALS INC0 citations60
US12116635B2Oct 15, 2024
Methods for detecting and treating cancers having adenosine pathway activation
CORVUS PHARMACEUTICALS INC0 citations60
US12023337B2Jul 2, 2024
Methods of treating cancer
CORVUS PHARMACEUTICALS INC0 citations58